Biolegend, 141705, PE anti-mouse CD206 (MMR) Antibody, 25μg

CD206, also known as mannose receptor (MR), is a 175 kD type I membrane protein. It is a pattern recognition receptor (PRR) belonging to the C-type lectin superfamily. MR is expressed on macrophages, dendritic cells, Langerhans cells, and hepatic or lymphatic endothelial cells. MR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine through its C-type lectin-like carbohydrate recognition domains, sulfated carbohydrate antigens through its cysteine-rich domain, and collagens through its fibronectin type II domain. MR mediates endocytosis and phagocytosis as well as activation of macrophages and antigen presentation. It plays an important role in host defense and provides a link between innate and adaptive immunity. Recently, MR on lymphatic endothelial cells was found to be involved in leukocyte trafficking and a contributor to the metastatic behavior of cancer cells. It suggests that MR may be a potential target in controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.
25μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Recombinant mouse CD206 (MMR)
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: ICFC - Quality testedFC - Verified
Recommended Usage: Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.
Application References(PubMed link indicates BioLegend citation): Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed Yang X, et al. 2015. PNAS. 112:2900. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Michela Miani et al. 2018. Cell metabolism. 28(4):557-572 . PubMed Feng Y, et al. 2018. J Am Soc Nephrol. 29:182. PubMed Seo JB, et al. 2019. Nat Metab. 1:86. PubMed Ying W, et al. 2019. Cell Metab. 29:457. PubMed Sun H, et al. 2019. Mol Hum Reprod. 25:05:00. PubMed Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed Lundahl MLE, et al. 2022. Elife. 11:. PubMed Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed Bautista CA, et al. 2023. Front Physiol. 14:1122348. PubMed Garabuczi É, et al. 2023. Front Immunol. 14:1139204. PubMed Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed Pan C, et al. 2023. Front Bioeng Biotechnol. 11:1129187. PubMed Levra Levron C, et al. 2023. Nat Cell Biol. 25:740. PubMed Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed Li T, et al. 2023. Nat Commun. 14:2498. PubMed Salemme V, et al. 2023. Nat Commun. 14:2350. PubMed Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed Cui J, et al. 2021. J Cell Mol Med. 25:5586. PubMed Zhang B, et al. 2022. Front Med (Lausanne). 8:796743. PubMed Wang HH, et al. 2022. J Biomed Sci. 29:36. PubMed Zhang Z, et al. 2022. Front Pharmacol. 13:906625. PubMed Yu L, et al. 2021. Cell Biol Int. 45:2452. PubMed Li H, et al. 2022. Cancer Cell. 40:36. PubMed Silveira DB, et al. 2022. Cell Biochem Funct. 40:163. PubMed Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed Lee R, et al. 2022. Cancer Discov. 12:1702. PubMed Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed Li D, et al. 2022. Cell Prolif. 55:e13299. PubMed Li Y, et al. 2023. Bioact Mater. 20:548. PubMed Liu Z, et al. 2022. Cancer Commun (Lond). 42:971. PubMed Meng Z, et al. 2022. Int J Oncol. 61: . PubMed Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed Li J, et al. 2023. Front Immunol. 13:945234. PubMed Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed Domingos-Pereira S, et al. 2022. Int J Mol Sci. 24: . PubMed Li Y, et al. 2023. Cell Death Dis. 14:28. PubMed Zhang L, et al. 2023. J Inflamm Res. 16:109. PubMed Fan R, et al. 2023. J Immunother Cancer. 11: . PubMed Chun J, et al. 2023. Cancers (Basel). 15: . PubMed Li S, et al. 2023. Exp Mol Med. 55:457. PubMed Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed Hu S, et al. 2018. Front Immunol. 9:01. PubMed Ying W et al. 2017. Cell. 171(2):372-384 . PubMed Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed Nomura M, et al. 2016. Nat Immunol. 17:216-217. PubMed Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed Zheng W, et al. 2021. Wellcome Open Research. 6:52. PubMed Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed Dong L, et al. 2021. Cancer Cell. . PubMed Clarke F,et al. 2017. PLoS One. 10.1371/journal.pone.0186625. PubMed Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed Sadek J, et al. 2021. EMBO Mol Med. 13:e13591. PubMed Li Q, et al. 2021. Front Immunol. 12:707784. PubMed Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed De Vlaeminck Y, et al. 2020. Cancers (Basel). 12:. PubMed Li J, et al. 2021. Front Immunol. 12:649285. PubMed Krukowski K, et al. 2021. Sci Adv. 7:eabg6702. PubMed Pajarinen J, et al. 2021. J Biomed Mater Res A. 109:1512. PubMed Shao H, et al. 2012. J Biol Chem. 287:35860. PubMed He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed Tang TT, et al. 2020. Sci Adv. 6:eaaz0748. PubMed Mul Fedele ML, et al. 2020. Front Cell Infect Microbiol. 10:100. PubMed El–Achkar GA, et al. 2019. PLoS One. 14:e0216405. PubMed Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed Tanner L, et al. 2022. Front Pharmacol. 13:899469. PubMed Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed Jia X, et al. 2021. Front Cell Dev Biol. 9:685522. PubMed Giri J, et al. 2020. Cell Rep. 30:1923. PubMed Dan H, et al. 2020. Mol Oncol. 14:795. PubMed Kim JS, et al. 2020. Int J Oncol. 56:1405. PubMed McKee AM, et al. 2021. iScience. 24:103012. PubMed Zhang Y, et al. 2022. Nat Commun. 13:4553. PubMed Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed Martins L, et al. 2020. Stem Cell Res Ther. 0.786805556. PubMed Farini A, et al. 2020. Front Physiol. 0.738194444. PubMed An W et al. 2019. British journal of pharmacology. 176(5):699-710 . PubMed Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed Jiao Y, et al. 2021. Crit Care. 25:356. PubMed Guérin MV, et al. 2019. Nat Commun. 10:4131. PubMed Liao T, et al. 2017. Front Immunol. 8:1334. PubMed Wang J, et al. 2021. Nat Commun. 12:6198. PubMed Lu X, et al. 2020. Sci Transl Med. 12:. PubMed Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed Lee DH, et al. 2019. PLoS One. 14:e0215727. PubMed Yu Y, et al. 2018. Mol Med Rep. 17:8212. PubMed Wei W, et al. 2022. mSystems. 7:e0046922. PubMed Wang Y, et al. 2022. Cell Death Dis. 13:748. PubMed Golden TN, et al. 2022. Front Pharmacol. 12:761496. PubMed Cai C, et al. 2021. Sci Rep. 11:13386. PubMed Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed Miura I, et al. 2021. Physiol Rep. 9:e14859. PubMed Li H, et al. 2021. Nat Commun. 12:7149. PubMed Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed Shu Y, et al. 2020. Immunology. 160:345. PubMed Ying W, et al. 2016. Sci Rep. 6:20176. PubMed Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed Chu SY, et al. 2019. Nat Commun. 10:1524. PubMed Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed Lu X, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2358. PubMed Bhattacharya A, et al. 2018. Neuropsychopharmacology. 43:2586. PubMed Qiu N, et al. 2021. J Nanobiotechnology. 19:428. PubMed Yang C, et al. 2022. Nat Commun. 13:4866. PubMed Lowe PP, et al. 2020. J Neuroinflammation. 0.913888889. PubMed Zhou K, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16648712. PubMed Deng W, et al. 2015. Clin Immunol. . PubMed Lu SW, et al. 2020. Nat Commun. 3.660416667. PubMed Anderson-Baucum E, et al. 2021. Cell Metab. 33:1883. PubMed Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed Wang X, et al. 2022. J Biol Chem. 298:101561. PubMed Asterholm I, et al. 2012. J Lipid Res. 53: 1254. PubMed Stridh L, et al. 2013. J Neurosci. 33:12401. PubMed Long L, et al. 2018. Bio Protoc. 8:e2815. PubMed Li C, et al. 2019. JCI Insight. 5. PubMed Budai Z, et al. 2021. Cells. 10:. PubMed Zhu Q, et al. 2022. Atherosclerosis. 357:41. PubMed Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed Krukowski K, et al. 2018. Sci Rep. 8:7857. PubMed Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed Li Y, et al. 2020. Theranostics. 10:2897. PubMed Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed Ukah T, et al. 2017. J Immunol. 10.4049/jimmunol.1700410. PubMed Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed Liu C, et al. 2022. Cell Death Discov. 8:269. PubMed Sears SM, et al. 2022. Kidney360. 3:818. PubMed Budhu S, et al. 2021. Cell Reports. 34(2):108620. PubMed Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed Browne A, et al. 2015. Cancer Res . 75: 2811 - 2821. PubMed Moreno M et al. 2014. The Journal of Neuroscience. 34(24):8175-85 . PubMed Zhang J, et al. 2020. J Cell Mol Med. 24:4547. PubMed Lau P, et al. 2022. Cell Mol Immunol. :. PubMed Liu YS, et al. 2021. Cancers (Basel). 13:. PubMed Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed Li B et al. 2019. Cell reports. 26(10):2720-2737 . PubMed Morioka S, et al. 2018. Nature. 563:714. PubMed Mellal K, et al. 2019. Sci Rep. 9:12903. PubMed Yuan Y, et al. 2019. Clin Sci (Lond). 133:1759. PubMed Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed Al-Zaeed N, et al. 2021. Cell Death Dis. 12:611. PubMed Golabek A, et al. 2021. Exp Ther Med. 21:482. PubMed Yeini E, et al. 2021. Nat Commun. 12:1912. PubMed Xu GY, et al. 2022. Small. 18:e2107838. PubMed Zheng H, et al. 2021. Frontiers in Immunology. 12:645100. PubMed Chuan Li et al. 2017. Endocrinology. 158(9):2837-2847 . PubMed Wen HJ, et al. 2019. Cell Mol Gastroenterol Hepatol. 8:p173. PubMed Yuan M, et al. 2017. Hum Reprod. 32:94. PubMed Riopel M, et al. 2019. Mol Metab. 20:89. PubMed Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed Cai T, et al. 2022. Front Immunol. 13:1009932. PubMed Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed Guo S, et al. 2021. Chronic Dis Transl Med. 7:254. PubMed
RRID: AB_10896421 (BioLegend Cat. No. 141705) AB_10895754 (BioLegend Cat. No. 141706)
Structure: Type I transmembrane protein, 175 kD, C-type lectin superfamily
Distribution: Macrophages, dendritic cells, Langerhans cells, liver endothelial cells
Function: Pathogen recognition, endocytosis and phagocytosis, antigen presentation
Ligand/Receptor: Antigen containing mannose, fucose, or an N-acetyl glucosamine
Cell Type: Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
Biology Area: Cell Biology, Immunology, Innate Immunity, Signal Transduction
Molecular Family: CD Molecules
Antigen References: 1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501. 2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469. 3. Burgdorf S, et al. 2006. J. Immunol. 176:6770. 4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.
Gene ID: 17533
UniProt: View information about CD206 on UniProt.org
Clone: C068C2
Regulatory Status: RUO
Other Names: MMR (macrophage mannose receptor), MR (mannose receptor), MRC1
Isotype: Rat IgG2a, κ
Q: What type of PE do you use in your conjugates?
A: We use R-PE in our conjugates.
Q: Why is mouse CD206 stained intracellularly and not via surface staining?
A: Typically, mouse CD206 surface level is relatively low under normal conditions and so intracellular staining protocol is required to get better signal.